172 related articles for article (PubMed ID: 21802503)
1. From cancer metabolism to new biomarkers and drug targets.
Chiaradonna F; Moresco RM; Airoldi C; Gaglio D; Palorini R; Nicotra F; Messa C; Alberghina L
Biotechnol Adv; 2012; 30(1):30-51. PubMed ID: 21802503
[TBL] [Abstract][Full Text] [Related]
2. MR evaluation of response to targeted treatment in cancer cells.
Podo F; Canevari S; Canese R; Pisanu ME; Ricci A; Iorio E
NMR Biomed; 2011 Jul; 24(6):648-72. PubMed ID: 21387442
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
4. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
5. Predicting drug targets and biomarkers of cancer via genome-scale metabolic modeling.
Jerby L; Ruppin E
Clin Cancer Res; 2012 Oct; 18(20):5572-84. PubMed ID: 23071359
[TBL] [Abstract][Full Text] [Related]
6. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.
Yalcin A; Telang S; Clem B; Chesney J
Exp Mol Pathol; 2009 Jun; 86(3):174-9. PubMed ID: 19454274
[TBL] [Abstract][Full Text] [Related]
7. Oncoproteomics.
Joshi S; Tiwari AK; Mondal B; Sharma A
Clin Chim Acta; 2011 Jan; 412(3-4):217-26. PubMed ID: 20955692
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiles of cancer cells.
Griffin JL; Shockcor JP
Nat Rev Cancer; 2004 Jul; 4(7):551-61. PubMed ID: 15229480
[No Abstract] [Full Text] [Related]
9. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
Pathania D; Millard M; Neamati N
Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
[TBL] [Abstract][Full Text] [Related]
10. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect.
Weljie AM; Jirik FR
Int J Biochem Cell Biol; 2011 Jul; 43(7):981-9. PubMed ID: 20797448
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
13. Targeting glucose metabolism: an emerging concept for anticancer therapy.
Madhok BM; Yeluri S; Perry SL; Hughes TA; Jayne DG
Am J Clin Oncol; 2011 Dec; 34(6):628-35. PubMed ID: 20805739
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell targeted agents: therapeutic approaches and consequences.
Chumsri S; Burger AM
Curr Opin Mol Ther; 2008 Aug; 10(4):323-33. PubMed ID: 18683096
[TBL] [Abstract][Full Text] [Related]
15. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
Corona G; Rizzolio F; Giordano A; Toffoli G
J Cell Physiol; 2012 Jul; 227(7):2827-31. PubMed ID: 22105661
[TBL] [Abstract][Full Text] [Related]
16. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell metabolism: cancer's Achilles' heel.
Kroemer G; Pouyssegur J
Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
[TBL] [Abstract][Full Text] [Related]
18. Interpretation of treatment results with biological agents: is there a need for a new methodology?
Begent RH
J BUON; 2007 Sep; 12 Suppl 1():S53-8. PubMed ID: 17935278
[TBL] [Abstract][Full Text] [Related]
19. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
20. [mTOR complexes -- molecular spiders in molecular networks].
Kopper L; Tímár J
Magy Onkol; 2011 Nov; 55(4):287-94. PubMed ID: 22128312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]